Clinical Implementation of Urinary Biomarkers for Surveillance of Non-muscle-invasive Bladder Cancer (NMIBC) : Considerations from the European Association of Urology NMIBC Guideline Panel
(2025) In European Urology Oncology 8(2). p.234-236- Abstract
Although high-level evidence is currently lacking, noninferiority randomised controlled trials in predefined risk groups in non-muscle-invasive bladder cancer are under way to scientifically prove the safety of urinary biomarker-guided follow-up. To facilitate recommendations for clinical use, it is essential to comply with the EU certification for in vitro diagnostics and to demonstrate cost effectiveness.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/cb422e8f-e5b8-4e46-9c9c-a6e66bc806df
- author
- Liedberg, Fredrik LU ; Mariappan, Paramananthan and Gontero, Paolo
- author collaboration
- organization
- publishing date
- 2025-04
- type
- Contribution to journal
- publication status
- published
- subject
- in
- European Urology Oncology
- volume
- 8
- issue
- 2
- pages
- 3 pages
- publisher
- Elsevier
- external identifiers
-
- scopus:105001982003
- pmid:39343636
- ISSN
- 2588-9311
- DOI
- 10.1016/j.euo.2024.09.011
- language
- English
- LU publication?
- yes
- id
- cb422e8f-e5b8-4e46-9c9c-a6e66bc806df
- date added to LUP
- 2025-08-26 10:25:06
- date last changed
- 2025-08-26 10:26:05
@misc{cb422e8f-e5b8-4e46-9c9c-a6e66bc806df, abstract = {{<p>Although high-level evidence is currently lacking, noninferiority randomised controlled trials in predefined risk groups in non-muscle-invasive bladder cancer are under way to scientifically prove the safety of urinary biomarker-guided follow-up. To facilitate recommendations for clinical use, it is essential to comply with the EU certification for in vitro diagnostics and to demonstrate cost effectiveness.</p>}}, author = {{Liedberg, Fredrik and Mariappan, Paramananthan and Gontero, Paolo}}, issn = {{2588-9311}}, language = {{eng}}, number = {{2}}, pages = {{234--236}}, publisher = {{Elsevier}}, series = {{European Urology Oncology}}, title = {{Clinical Implementation of Urinary Biomarkers for Surveillance of Non-muscle-invasive Bladder Cancer (NMIBC) : Considerations from the European Association of Urology NMIBC Guideline Panel}}, url = {{http://dx.doi.org/10.1016/j.euo.2024.09.011}}, doi = {{10.1016/j.euo.2024.09.011}}, volume = {{8}}, year = {{2025}}, }